Impact of Secondary Aortic Interventions after Thoracic Endovascular Aortic Repair on Long Term Survival.
The indications and technology surrounding thoracic endovascular aortic repair (TEVAR) have undergone significant evolution with increasing adoption. The purpose of this report is to evaluate pathology specific incidence, timing and types of secondary aortic interventions (SAI) after TEVAR and their impact on survival. Single center retrospective review of all TEVARs and SAI performed from 2004-2018. Kaplan-Meier and multivariable logistic regression were used to estimate freedom from SAI, survival, and identify SAI predictors. 1037 patients (mean age: 65.4±15.1), 155 (14.9%) underwent 212 SAIs [median 5 (interquartile range, 1.5-18) months] with 37 (3.6%) requiring multiple SAI. The primary aortic pathology at index TEVAR significantly affected the incidence of SAI (P=.0001) [chronic dissection (26.5%), post-surgical anastomotic pseudoaneurysm (19.4%), degenerative aneurysm (15.3%) and acute dissection (11.2%)]. The most common indications for SAI were endoleaks (44.8%), disease progression and/or remote aortic procedure (23.1%) and persistent false lumen flow (9.9%). After exclusion of 30-day mortality events, patients who did not undergo a SAI had better survival vs subjects experiencing SAI [[No-SAI 1-year, 88.8%±1.1; 5-years 75.2%±1.7; 10-year 66.5%±2.3; and SAI 1-year 91.7%±2.4; 5-year 61.9%±4.9; 10-year 33.5%±8.4 (log-rank, P=.004)] CONCLUSIONS: SAI after TEVAR is not uncommon, particularly in patients with chronic dissection pathology. Patients surviving their index hospitalization who experience SAI have worse long-term survival. The varying incidence of SAI by indication identifies the need for pathology specified patient selection, surveillance strategies after TEVAR and better device design that addresses the limitations of TEVAR particularly in dealing with dissection-related indications.